Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
BRISTOL MYERS SQUIBB CO (BMY)
Sector: Healthcare; Industry: Drug Manufacturers—General

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products in the following therapeutic classes: hematology, oncology, cardiovascular, and immunology. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-05-10 Eid Joseph SVP, Head Glob. Medical Affairs Sell 1,118 $65.00 $72,670 No
2021-05-10 Schmukler Louis S EVP, Pres., Glob.Prod. & Supply Sell 15,000 $65.25 $978,750 No
2021-05-05 Dubow Adam SVP, ChiefCompliance&EthicsOff. Sell 3,119 $64.21 $200,271 No
2021-05-05 VESSEY RUPERT EVP, Research & Early Dev. Sell 30,546 $64.29 $1,963,802 No
2021-03-22 Caforio Giovanni Chairman and CEO Sell 25,000 $62.20 $1,555,000 No
2020-11-25 von Autenried Paul EVP, Chief Information Officer Sell 3 $63.50 $190 No
2020-11-23 VESSEY RUPERT EVP, Research & Early Dev. Sell 13,421 $61.34 $823,244 No
2020-11-24 Dubow Adam SVP, ChiefCompliance&EthicsOff. Sell 900 $63.39 $57,051 No
2020-11-24 von Autenried Paul EVP, Chief Information Officer Sell 20,000 $62.75 $1,255,000 No
2020-11-19 VESSEY RUPERT EVP, Research & Early Dev. Sell 57,591 $61.30 $3,530,269 Yes
2020-08-31 Caforio Giovanni Chairman and CEO Sell 39,840 $62.70 $2,497,968 No
2020-08-17 Eid Joseph SVP, Head Glob. Medical Affairs Sell 5,327 $64.00 $340,928 No
2020-08-13 LEUNG SANDRA EVP, General Counsel Sell 141,420 $63.24 $8,943,401 No
2020-06-15 Paliwal Dinesh C Director Buy 9,174 $54.50 $499,983 No
2019-12-04 BONNEY MICHAEL W Director Buy 88 $58.90 $5,183 No
2020-05-22 Dubow Adam SVP, ChiefCompliance&EthicsOff. Sell 3,200 $61.01 $195,232 No
2020-05-19 Schmukler Louis S EVP, Pres., Glob.Prod. & Supply Sell 25,000 $62.68 $1,567,000 No
2020-03-04 Elicker John E EVP, Investor Relations Sell 15,805 $61.01 $964,263 No
2020-03-02 VESSEY RUPERT Pres., Research & Early Dev. Sell 84,308 $60.59 $5,108,222 Yes
2019-12-05 Dubow Adam Chief Compliance & Ethics Offi Sell 1,740 $58.81 $102,329 No
2019-11-05 Schmukler Louis S Pres., Global Mfg. & Supply Sell 25,000 $56.56 $1,414,000 No
2019-11-05 Elicker John E SVP, Public Affairs & IR Sell 15,000 $56.66 $849,900 No
2019-07-31 BERTOLINI ROBERT J Director Buy 11,000 $44.72 $491,920 No
2019-05-16 Santiago Karen Murphy Controller Sell 3,065 $47.56 $145,771 No
2019-05-16 Samuels Theodore R. II Director Buy 5,000 $47.29 $236,440 No
2018-04-30 Paliwal Dinesh C Director Buy 9,540 $52.40 $499,896 No
2018-04-30 Paliwal Dinesh C Director Buy 4,770 $52.40 $249,948 No
2017-12-15 Samuels Theodore R. II Director Buy 4,000 $62.30 $249,187 No
2017-12-12 Lynch Thomas J. Jr. EVP & Chief Scientific Officer Sell 5,300 $63.24 $335,172 No
2017-12-04 LEUNG SANDRA EVP, General Counsel Sell 156,582 $63.37 $9,922,601 Yes

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.

Insider Smart

Carvana Co (CVNA) - One of the best timed insider buying in the crash is from GARCIA ERNEST C. II 10%-owner of CVNA. Bought at 45 and now with a 100%+ profit.